Aim: This study sought to compare the fracture resistance of three trademarked orthodontic mini-implants in the transmucosal profile region. Thirty-six mini-implants of three different brands, separated into groups I, II and III, were tested. Each group consisted of 12 mini-implants of 6 mm in length. The mean diameter and length of the transmucosal profile of the mini-implants were 1.90 and 2.0 mm in group I, 1.77 and 1.0 mm in group II and 1.50 and 1.0 mm in group III, respectively. The tests were performed on a universal testing machine in compression mode, with a 2,000 kgf load, a speed of 4.0 mm per minute and a chisel-shaped active tip, which acted crosssectionally on the transmucosal profile. Single-criterion analysis of variance was used to compare the three brands. A significance level of 5% and test power of 80% were adopted. The mean fracture resistance achieved by the mini-implants was 172.03 ± 25.59 N for group I, 162.35 ± 30.81 N for group II and 139.69 ± 42.99 N for group III. There was no statistically significant difference in mean fracture resistance among the tested mini-implant brands.
Conclusion:The transmucosal profile diameter does not seem to be a deciding factor in the choice of mini-implants to minimize the risk of fractures.
Clinical significance:Although being an in vitro study it is possible to believe that this new brand has a very satisfactory resistance to fracture and enables its use with great efficiency.
Heat treatment carried out in the region corresponding to the first molar distal region on thermoactivated nickel-titanium archwires did not influence the load/deflection values in adjacent portion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.